Fachliteratur Gastroenterologie: Funktionelle Beschwerden

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Magen-Darm » Funktionelle Beschwerden

18. November 2024

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Funktionelle Beschwerden

Schrift:

Seite 1 von 440


	Artikel 1 - 20 / 8783

	Editorial: Rebuilding Rome-Revising Diagnostic Criteria for Irritable Bowel Syndrome. Aliment Pharmacol Ther Butt MF, Corsetti M. PMID: 39543836 [PubMed - as supplied by publisher]
	Exploring online health resources and self-care among irritable bowel syndrome patients: analyzing internet use and AI chatbot interactions. Mhealth Altamimi I, Khan SA, Alhemsi H, Alhumimidi A, Alsulaim KB, Altoom F, Alomri F, Almutairi H, Alshankiti S, Alnobani O, Temsah MH, Jamal AA. PMID: 39534455 [PubMed]
	Water Avoidance-Stress Induces Differential Colon Transcriptomic Responses in BALB/c and C57BL/6 Mice Irritable Bowel Syndrome Model. Gastro Hep Adv Pang S, Higgins GA, Wiley JW, Hou X, Lin R, Zheng G. PMID: 39529650 [PubMed]
	Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndrome. BMJ Open Olson JL, Palumbo A, Desjardins C, Wicks C, Bhopa S, Cheyne K, D'Silva A, Graff LA, Narula N, Rodrigues DM, Fernandes A, Marshall DA, Moayyedi P, Presseau J. PMID: 39521469 [PubMed - indexed for MEDLINE]
	Personalisation of therapy in irritable bowel syndrome: a hypothesis. Lancet Gastroenterol Hepatol Black CJ, Ford AC. PMID: 39521004 [PubMed - indexed for MEDLINE]
	Dietary management of irritable bowel syndrome: considerations, challenges, and solutions. Lancet Gastroenterol Hepatol Whelan K, Ford AC, Burton-Murray H, Staudacher HM. PMID: 39521003 [PubMed - indexed for MEDLINE]
	Practices and Barriers in Implementing the Low FODMAP Diet for Irritable Bowel Syndrome Among Malaysian Dietitians: A Qualitative Study. Nutrients Ke TJ, Sameeha MJ, Siah KTH, Jeffri PBQB, Idrus NAB, Krishnasamy S. PMID: 39519430 [PubMed - indexed for MEDLINE]
	Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review. J Clin Med Lopes CM, de Jesus Monteiro CS, Duarte AP, Dos Santos JL. PMID: 39518476 [PubMed]
	Novel hypothesis and therapeutic interventions for irritable bowel syndrome: interplay between metal dyshomeostasis, gastrointestinal dysfunction, and neuropsychiatric symptoms. Mol Cell Biochem Nakagawa Y, Yamada S. PMID: 39503802 [PubMed - as supplied by publisher]
	A service evaluation of FODMAP restriction, FODMAP reintroduction and long-term follow-up in the dietary management of irritable bowel syndrome. J Hum Nutr Diet Foulkes R, Shah P, Twomey A, Dami L, Jones D, Lomer MCE. PMID: 39498596 [PubMed - as supplied by publisher]
	Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome. Therap Adv Gastroenterol Khan A, Menon R, Corning B, Cohn S, Kumfa C, Raji M. PMID: 39493642 [PubMed]
	The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT. PLoS One König J, Roca Rubio MF, Forsgård RA, Rode J, Axelsson J, Grompone G, Brummer RJ. PMID: 39485760 [PubMed - indexed for MEDLINE]
	Gut microbiota and irritable bowel syndrome: status and prospect. Front Med (Lausanne) Cheng X, Ren C, Mei X, Jiang Y, Zhou Y. PMID: 39484201 [PubMed]
	Dietary Interventions in Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes, Microbiota Changes, and Inflammatory Markers. Cureus Shams M, Ahmed J, Umar A, Rehman A, Sohail K, Javed B, Mustafa R, Payal F, Shehryar A, Khan M. PMID: 39483931 [PubMed]
	Association Between Stress, Neuroinflammation, and Irritable Bowel Syndrome: The Positive Effects of Probiotic Therapy. Cell Biochem Funct Azarfarin M, Moradikor N, Matin S, Dadkhah M. PMID: 39487668 [PubMed - indexed for MEDLINE]
	A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome. Clin Drug Investig Mokhtare M, Fathi M, Sadeghian AM, Sotoudeheian MJ, Namazi A. PMID: 39476291 [PubMed - indexed for MEDLINE]
	A Cross-Sectional Study of the Prevalence of Irritable Bowel Syndrome and Its Association With Anxiety and Depression Among Nurses in the Al-Qassim Region of Saudi Arabia. Cureus Alqifari AN, Alharbi SG, Alayed FM, Alabdullatif NH, Aljardan SA, Alqifari HN. PMID: 39469355 [PubMed]
	Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Aliment Pharmacol Ther Goodoory VC, Riggott C, Khasawneh M, Black CJ, Ford AC. PMID: 39466700 [PubMed - as supplied by publisher]
	Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options. Microorganisms Pastras P, Aggeletopoulou I, Triantos C. PMID: 39458345 [PubMed]
	Association Between Irritable Bowel Syndrome and Lower Urinary Tract Symptomatology: A Cross-sectional Study in Mexican Population. J Clin Gastroenterol Felix-Tellez FA, Del Rio O Brien MF, Ibarra Tapia ME, Escobar Montes MA, Peña Barajas GJ, Mercado Basoco SA, González Gómez FG, Remes-Troche JM, Velarde-Ruiz-Velasco JA. PMID: 39453697 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 8783

Seite 1 von 440



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung